Sonoma Pharmaceuticals (SNOA) Interest & Investment Income (2010 - 2021)
Sonoma Pharmaceuticals (SNOA) posted quarterly Interest & Investment Income of $2000.0 for Q1 2021, up 102.99% year-over-year from $985.29 in Q1 2020, and down 33.33% quarter-over-quarter from $3000.0 in Q4 2020.
Sonoma Pharmaceuticals (SNOA) Interest & Investment Income (2010 - 2021) Analysis & Trends
Sonoma Pharmaceuticals' Interest & Investment Income history runs 12 years deep, the most recent figure standing at $2000.0 for Q1 2021.
- In Q1 2021, Interest & Investment Income rose 102.99% year-over-year to $2000.0; the TTM figure through Mar 2021 stood at $15000.0 (down 70.0% YoY), while the FY2021 annual figure was $16000.0, down 68.0% from the prior year.
- Interest & Investment Income for Q1 2021 stood at $2000.0, down from $3000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $173000.0 in Q1 2018, with the low at -$67000.0 in Q1 2020.
- The 5-year median for Interest & Investment Income is $33000.0 (2019), against an average of $31000.0.
- The sharpest annual moves came in 2017 and 2020: Interest & Investment Income jumped 5200.0% in 2017, then sank 231.37% in 2020.
- Sonoma Pharmaceuticals' Interest & Investment Income stood at $14000.0 in 2017, then surged by 164.29% to $37000.0 in 2018, then fell by 10.81% to $33000.0 in 2019, then sank by 90.91% to $3000.0 in 2020, then plunged by 33.33% to $2000.0 in 2021.
- Business Quant data shows SNOA's Interest & Investment Income at $2000.0 in Q1 2021, $3000.0 in Q4 2020, and $8000.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.19 Mn | -145,899.91 | 2.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 3,000.00 |
| Sep 30, 2020 | 8,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | -67,000.00 |
| Dec 31, 2019 | 33,000.00 |
| Sep 30, 2019 | 42,000.00 |
| Jun 30, 2019 | 42,000.00 |
| Mar 31, 2019 | 51,000.00 |
| Dec 31, 2018 | 37,000.00 |
| Sep 30, 2018 | 47,000.00 |
| Jun 30, 2018 | 55,000.00 |
| Mar 31, 2018 | 173,000.00 |
| Dec 31, 2017 | 14,000.00 |
| Sep 30, 2017 | 18,000.00 |
| Jun 30, 2017 | 53,000.00 |
| Mar 31, 2017 | 14,000.00 |
| Dec 31, 2016 | 6,000.00 |
| Sep 30, 2016 | 1,000.00 |
| Jun 30, 2016 | 1,000.00 |